The Cambridge Centre for Advanced Research and Education in Singapore (CARES)

The Cambridge Centre for Advanced Research and Education in Singapore (CARES)
Name	Cambridge Centre for Advanced Research and Education in Singapore (CARES)
Established	2017
Type	Research institute
City	Singapore
Country	Singapore
Affiliations	University of Cambridge, National University of Singapore, Agency for Science, Technology and Research

The Cambridge Centre for Advanced Research and Education in Singapore (CARES) The Cambridge Centre for Advanced Research and Education in Singapore (CARES) is a research and training institute established to foster translational science, clinical innovation, and postgraduate instruction through international partnership. Located in Singapore, CARES functions as a hub linking British and Singaporean academic networks, fostering collaboration across biomedical, engineering, and computational domains. The centre emphasizes multidisciplinary research, industry engagement, and capacity building with an orientation toward clinical translation and technology transfer.

History

CARES was launched following memoranda between representatives of the University of Cambridge, the National University of Singapore, and Singaporean research bodies in the late 2010s. Its creation followed precedents set by transnational initiatives involving the Medical Research Council, the Wellcome Trust, and bilateral programmes such as the UK-Singapore Strategic Partnership. Early backers included figures and organizations from the Cambridge Biomedical Campus, the National Research Foundation (Singapore), and the Agency for Science, Technology and Research. Initial leadership drew on experience from units associated with the School of Clinical Medicine (Cambridge), the Cambridge Enterprise, and collaborations with the Duke–NUS Medical School and the Yong Loo Lin School of Medicine. CARES’ formative projects mirrored models used by the Francis Crick Institute, the European Molecular Biology Laboratory, and the Sanger Institute in coordinating large-scale translational pipelines. Over subsequent years CARES expanded its remit, aligning with initiatives like the Precision Medicine Initiative and regional platforms such as the Asia-Pacific Economic Cooperation research dialogues.

Campus and Facilities

The CARES campus occupies purpose-adapted laboratory and translational space within a Singaporean research precinct, designed to integrate wet laboratories, dry-lab computational suites, and clinical trial facilitation units. Facilities were modelled on infrastructure seen at the Cambridge Biomedical Campus, the John Radcliffe Hospital translational hubs, and the Bioscience Research and Innovation Centre (BRIC). Core installations include high-throughput sequencing laboratories similar to those at the Sanger Institute, imaging suites drawing on methods from the MRC Laboratory of Molecular Biology, and biomanufacturing pilot lines akin to the setups at the BioManufacturing Technology Centre. Computational facilities incorporate cluster resources comparable to the European Grid Infrastructure and connect to regional data nodes used by projects such as the Global Alliance for Genomics and Health. Clinical translation is supported through partnerships with hospitals including the Singapore General Hospital, the Tan Tock Seng Hospital, and specialist centres inspired by the Addenbrooke's Hospital model.

Academic Programs and Research

CARES hosts postgraduate training programmes and short-course executive education in translational science, drawing pedagogical frameworks from the University of Cambridge graduate programmes, the National University of Singapore doctoral schools, and professional development models by the Institute of Continuing Education (Cambridge). Research portfolios emphasize biomedical engineering, genomics, immunotherapy, and digital health. Projects reflect methodologies deployed at institutions such as the Wellcome Sanger Institute, the European Molecular Biology Laboratory, the Broad Institute, and the Johns Hopkins University medical research centres. CARES supervises PhD candidates in collaboration with departments equivalent to the Department of Medicine (Cambridge), the Department of Engineering (Cambridge), and the Saw Swee Hock School of Public Health. Research outputs have intersected with global consortia including the Human Cell Atlas, the 100,000 Genomes Project, and regional initiatives led by the Asia-Pacific Genome Network.

Partnerships and Collaborations

Partnerships form the operational backbone of CARES, spanning universities, hospitals, funding agencies, and industry. Academic partners include the University of Cambridge, the National University of Singapore, the Imperial College London, and the Duke University global health units. Clinical collaborators include the Singapore General Hospital and specialist institutes modelled on the Cambridge University Hospitals NHS Foundation Trust. Industry engagement has involved multinational corporations comparable to GlaxoSmithKline, Roche, Pfizer, and startups from incubators like Cambridge Innovation Capital and the Block71 ecosystem. Funding and project consortia have included the Wellcome Trust, the European Research Council, the National Institutes of Health, and regional funders such as the Temasek Foundation. CARES also participates in networks resembling the Association of Southeast Asian Nations research collaboratives and liaises with policy fora similar to the World Health Organization technical working groups.

Governance and Funding

Governance at CARES follows a board-and-director model, with governance structures influenced by supervisory frameworks at the University of Cambridge and corporate models used by the Wellcome Trust. The executive leadership team has typically combined academic directors with administrators experienced at the Cambridge Enterprise and regional research management entities such as the National Research Foundation (Singapore). Funding sources comprise competitive grants from bodies analogous to the Medical Research Council, philanthropic endowments in the style of the Wellcome Trust, institutional contributions from partner universities, and industry-sponsored research agreements with companies comparable to Novartis and AstraZeneca. Financial oversight practices reflect standards used by major research institutes such as the Francis Crick Institute and align with audit protocols common to large university research centres.

Notable Projects and Impact

CARES has been associated with translational projects spanning precision oncology, infectious disease surveillance, biomedical device prototyping, and health data science. Notable initiatives mirror efforts like the Human Genome Project-derived sequencing consortia, clinical trials patterned after those run at the National Institutes of Health Clinical Center, and device pathways comparable to collaborations with the Medical Research Council Technology. Impact includes contributions to regional capacity in genomic surveillance akin to work by the Global Influenza Surveillance and Response System, training cohorts for clinical translation modeled after the NIHR Academy, and startup spin-outs that echo trajectories of companies fostered by Cambridge Enterprise and NUS Enterprise. CARES’ outputs have informed policy dialogues in forums similar to the Asia-Europe Meeting and have been cited in collaborative reports alongside organizations like the World Health Organization and the Wellcome Trust.

Category:Research institutes in Singapore